We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$156B
1-Year Est. Return
27.51%
This Fund
S&P 500
This Quarter
Est. Return
+5.54%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.77%
AUM
$49.6B
AUM Growth
+$5.62B
(+13%)
Cap. Flow
+$2.56B
Cap. Flow
% of AUM
5.15%
Top 10 Holdings %
Top 10 Hldgs %
6.81%
Holding
1,885
New
111
Increased
738
Reduced
863
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$178M |
| 2 |
Schwab Fundamental International Large Company Index ETF
FNDF
|
+$161M |
| 3 |
KLA
KLAC
|
+$151M |
| 4 |
Zions Bancorporation
ZION
|
+$148M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ingredion
INGR
|
+$85.6M |
| 2 |
Keysight
KEYS
|
+$83.3M |
| 3 |
ATI
ATI
|
+$81.4M |
| 4 |
Kennametal
KMT
|
+$66.6M |
| 5 |
Keurig Dr Pepper
KDP
|
+$65.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.46% |
| 2 | Industrials | 15.08% |
| 3 | Technology | 14.03% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Liberty Energy
LBRT
$3.23B
| $79K | ﹤0.01% |
4,868
-8,455
| -63% | -$130K |
|
|
PCMI
1627
DELISTED
PCM, Inc
PCMI
| $77K | ﹤0.01% |
2,197
-3,820
| -63% | -$113K |
|
1628
Capri Holdings
CPRI
$1.87B
| $76K | ﹤0.01% |
2,180
-56
| -3% | -$2.28K |
|
1629
News Corp Class A
NWSA
$15.3B
| $75K | ﹤0.01% |
5,526
-119
| -2% | -$1.45K |
|
|
EBIX
1630
DELISTED
Ebix Inc
EBIX
| $74K | ﹤0.01% |
1,478
-2,566
| -63% | -$128K |
|
1631
Stoke Therapeutics
STOK
$1.94B
| $73K | ﹤0.01% |
+2,500
| New | +$67.1K |
|
|
ROIC
1632
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $73K | ﹤0.01% |
4,237
-1,583
| -27% | -$27.4K |
|
|
MNR
1633
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $73K | ﹤0.01% |
5,375
-6,355
| -54% | -$87.3K |
|
1634
AdvanSix
ASIX
$541M
| $72K | ﹤0.01% |
2,965
-5,153
| -63% | -$144K |
|
1635
Jefferies Financial Group
JEF
$12.9B
| $72K | ﹤0.01% |
4,160
-144
| -3% | -$2.47K |
|
|
SNBR
1636
DELISTED
Sleep Number
SNBR
| $72K | ﹤0.01% |
1,771
-3,075
| -63% | -$119K |
|
1637
ArcBest
ARCB
$3.21B
| $71K | ﹤0.01% |
2,525
-4,390
| -63% | -$128K |
|
1638
LeMaitre Vascular
LMAT
$2.4B
| $71K | ﹤0.01% |
2,527
-4,394
| -63% | -$122K |
|
1639
Future Fuel
FF
$218M
| $70K | ﹤0.01% |
5,972
-10,381
| -63% | -$129K |
|
1640
Pebblebrook Hotel Trust
PEB
$2.17B
| $70K | ﹤0.01% |
2,481
-1,227
| -33% | -$37.1K |
|
1641
Amkor Technology
AMKR
$14B
| $69K | ﹤0.01% |
9,249
-16,074
| -63% | -$126K |
|
1642
Funko
FNKO
$320M
| $68K | ﹤0.01% |
2,793
-4,850
| -63% | -$103K |
|
1643
Helios Technologies
HLIO
$2.7B
| $68K | ﹤0.01% |
1,463
-2,537
| -63% | -$118K |
|
1644
Kilroy Realty
KRC
$4.58B
| $68K | ﹤0.01% |
927
-2,005
| -68% | -$152K |
|
1645
Under Armour
UAA
$2.9B
| $68K | ﹤0.01% |
2,694
-57
| -2% | -$1.34K |
|
1646
Arrowhead Research
ARWR
$12.5B
| $67K | ﹤0.01% |
2,513
| – | – |
|
1647
Enanta Pharmaceuticals
ENTA
$384M
| $67K | ﹤0.01% |
793
-1,377
| -63% | -$124K |
|
1648
Supernus Pharmaceuticals
SUPN
$2.56B
| $67K | ﹤0.01% |
2,019
-3,507
| -63% | -$120K |
|
1649
Sally Beauty Holdings
SBH
$1.58B
| $66K | ﹤0.01% |
4,942
-8,593
| -63% | -$140K |
|
1650
Unisys
UIS
$223M
| $66K | ﹤0.01% |
6,814
-11,842
| -63% | -$122K |
|
Similar funds
Victory Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Victory Capital Management held 1,885 positions worth $49.6B, up 13% from $44B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
Victory Capital Management deployed $2.56B of net new capital in Q2 2019, opening 111 new positions and adding to 738 existing holdings. Its largest new stake was Goldman Sachs ActiveBeta US Large Cap Equity ETF: 3,081,520 shares worth $181M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Ingredion, an estimated $85.6M trimmed.
- Victory Capital Management's largest Q2 2019 buy was Goldman Sachs ActiveBeta US Large Cap Equity ETF: 3,081,520 shares worth $181M.
- Victory Capital Management added most to KLA in Q2 2019, an estimated $151M increase.
- Victory Capital Management's biggest Q2 2019 reduction was Ingredion, cutting an estimated $85.6M.
- Victory Capital Management fully exited Teladoc Health in Q2 2019, selling an estimated $50.5M.
- Victory Capital Management's ten largest holdings make up 6.8% of its $49.6B portfolio in Q2 2019.
- Victory Capital Management opened 111 new positions and closed 63 in Q2 2019.
- Victory Capital Management's portfolio value rose 13% quarter-over-quarter to $49.6B.
Based on Victory Capital Management's 13F filing for Q2 2019, filed 15 Aug 2019.